ePoster 26
Urology (case)
October 20 (Fri) 11:20 - 12:05 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P26-1Urology (case) Successful embolic therapy for mesenteric varices of ileal conduit in a patient with liver cirrhosis
[Speaker] Ayaka Sakurai:1,2 1:Urology, Hospital, Gunma University, 2:Urology, Isesaki Municipal Hospital |
|
P26-2Urology (case) Vaginal metastasis of bladder cancer after total cystectomy
[Speaker] Satoru Maruyama:1 1:Urology, National Hospital Organization -Hokkaido Cancer Center- |
|
P26-3Urology (case) A case of urothelial carcinoma arising in the retroperitoneum after bladder diverticulectomy
[Speaker] Akira Ohtsu:1 1:Urology, Hospital, Gunma University |
|
P26-4Urology (case) Bilateral fumarate hydratase deficient renal cell carcinoma in a patient with hereditaryleiomyomatosis and renal cell cancer syndrome
[Speaker] Akihiro Ono:1 1:NTT Medical Center Tokyo |
|
P26-5Urology (case) Four cases of very elderly prostate cancer treated with novel androgen receptor axis-targeted agents (ARATs)
[Speaker] Satoshi Honda:1,2 1:Oda Training Center of General Practice, Department of General Medicine, Faculty of Medicine, Shimane University, 2:Department of Urology, Oda Municipal Hospital |
|
P26-6Urology (case) Radiation therapy for lymphatic oligometastesis in castration resistant prostate cancer in 2 cases
[Speaker] Tsuyoshi Furuno:1 1:Department of urology, Hokkaido Memorial Hospital of Urology |
ePoster 27
Prostate (radiation)
October 20 (Fri) 13:35 - 14:25 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P27-1Prostate (radiation) Feasibility of single fraction high-dose-rate brachytherapy as monotherapy for localized prostate cancer
[Speaker] Shingo Ashida:1 1:Department of Urology, Kochi Medical School, Kochi University |
|
P27-2Prostate (radiation) Carbon-ion radiotherapy for high-risk prostate cancer in Gunma University Heavy Ion Medical Center
[Speaker] Hiroshi Matsui:1,2 1:Heavy Ion Medical Center, Gunma University, 2:Department of Urology, Graduate School of Medicine, Gunma University |
|
P27-3Prostate (radiation) Comparison of outcomes between robot assisted radical prostatectomy and high-dose-rate brachytherapy with hormonal therapy for high-risk prostate cancer
[Speaker] Takahito Wakamiya:1 1:Urology, Hospital, Wakayama Medical University |
|
P27-4Prostate (radiation) A comparative study of treatment outcomes of RARP and HDR-BT in high-risk prostate cancer patients
[Speaker] Fumio Ishizaki:1 1:Department of Urology, Graduate School of Medical and Dental Sciences, Niigata University |
|
P27-5Prostate (radiation) Long-term outcomes of whole pelvic radiation therapy using VMAT for high-risk prostate cancer
[Speaker] Reiko Takemura:1 1:Tane General Hospital |
|
P27-6Prostate (radiation) Daikenchuto Therapy Reduces the Rectal Bleeding Rate After IMRT for Prostate Cancer
[Speaker] Masateru Fujiwara:1 1:Department of Radiation Oncology, Suita Tokushukai Hospital |
|
P27-7Prostate (radiation) The subjective efficacy of Traditional Japanese Herbal Medicine Ryutanshakanto for lower urinary tract symptoms during or after definitive radiotherapy for prostate cancer
[Speaker] Fumio Ayukawa:1 1:Department of Radiotherapy, Niigata Cancer Center Hospital |
ePoster 28
Prostate (surgery, QOL)
October 20 (Fri) 14:25 - 15:10 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P28-1Prostate (surgery, QOL) A retrospective analysis investigating incidents of delayed biochemical recurrence following retropubic radical prostatectomy
[Speaker] Norihiko Kawamura:1 1:Department of Urology, Osaka International Cancer Institute |
| P28-2Prostate (surgery, QOL) Withdrawn |
|
P28-3Prostate (surgery, QOL) Clinical experiences of laparoscopic radical prostatectomy using Japanese surgical robot HINOTORI first 21 cases in a single hospital
[Speaker] Hideki Mukouyama:1 1:Urology, Okinawa Nanbu Tokushukai Hospital |
|
P28-4Prostate (surgery, QOL) Examination of sexual function affecting satisfaction after robot-assisted radical prostatectomy
[Speaker] Hidekazu Koike:1 1:Urology, Hospital, Gunma University |
|
P28-5Prostate (surgery, QOL) Sanitary Boxes in Men's Restrooms Are Necessary - Recommendations from a Survey of Postoperative Prostate Cancer Patients
[Speaker] Yoshiko Maeda:1 1:Department of Urology, School of Medicine, Showa University |
|
P28-6Prostate (surgery, QOL) Comprehensive geriatric assessment (CGA) of patients prior initial prostate cancer treatment
[Speaker] Hiroshi Nagae:1 1:Nagae Prostate Care Clinic |
ePoster 29
Prostate (drug) 1
October 20 (Fri) 15:45 - 16:30 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P29-1Prostate (drug) Results of upfront therapy for metastatic castration sensitive prostate cancer in our hospital
[Speaker] Yuta Goto:1 1:Oohunato Hospital |
|
P29-2Prostate (drug) Trends of treatment selection in patents with mCSPC in the era of upfront combination therapy
[Speaker] Kyo Togashi:1 1:Department of Urology, School of Medicine & Hospital, Hirosaki University |
|
P29-3Prostate (drug) A study to evaluate the long term efficacy and safety of enzalutamide in patients with castration-resistant prostate cancer; multicenter, prospective DELC study
[Speaker] Mototaka Sato:1 1:Urology, Toyonaka Municipal Hospital |
|
P29-4Prostate (drug) Evaluation of Treatment Outcomes of Abiraterone and Enzalutamide for Castration-Resistant Prostate Cancer at Our Institution
[Speaker] Kota Inage:1 1:Yamanashi Prefectural Central Hospital |
|
P29-5Prostate (drug) Factors Associated with the Efficacy of Cabazitaxel Therapy in Patients with Castration-Resistant Prostate Cancer
[Speaker] Ryota Ogura:1 1:Urology, School of Medicine, Kyoto Prefectural University of Medicine |
|
P29-6Prostate (drug) Retrospective analysis of chemotherapy for castration resistant prostate cancer in Kyushu Cancer Center
[Speaker] Toshiki Koga:1 1:Department of Urology, National Hospital Organization Kyushu Cancer Center |
ePoster 30
Prostate (drug) 2
October 20 (Fri) 16:35 - 17:20 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P30-1Prostate (drug) Do androgen receptor axis-targeted agents improve metastatic hormone-sensitive prostate cancer outcomes in elderly patients?
[Speaker] Nami Tomiyama:1 1:Urology, Gamagori City Hospital |
|
P30-2Prostate (drug) Clinical outcome of upfront androgen receptor signaling inhibitors for metastatic castration-sensitive prostate cancer
[Speaker] Shinichiro Higashi:1 1:Nephro-Urologic Surgery and Andrology, Hospital, Mie University |
| P30-3Prostate (drug) Withdrawn |
| P30-4Prostate (drug) Withdrawn |
|
P30-5Prostate (drug) Olaparib for hereditary BRCA2-mutated prostate cancer: first case experienced at our facility
[Speaker] Ryoma Kurahashi:1 1:Department of Urology, Faculty of Life Sciences, Kumamoto University |
|
P30-6Prostate (drug) Initial experience with olaparib treatment for castration-resistant prostate cancer at Osaka Rosai Hospital
[Speaker] Takeshi Ujike:1 1:Osaka Rosai Hospital |
ePoster 31
Gynecology
October 20 (Fri) 8:30 - 9:20 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P31-1Gynecology Limitations of cervical cytology as a screening test in the diagnosis of cervical cancer
[Speaker] Kosuke Shigematsu:1 1:Department of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University |
|
P31-2Gynecology Challenging differential diagnosis: whole-exome sequencing aids in identifying two cases of peritoneal dissemination of endometrial cancer resembling endometriosis-originated cancer
[Speaker] Koichi Watanabe:1,2 1:Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, 2:Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University |
|
P31-3Gynecology Long-term survival after surgical resection of platinum-refractory bilateral pulmonary metastases in endometrial carcinoma patients. A report of two cases
[Speaker] Isao Otsuka:1 1:Department of Obstetrics and Gynecology, Kameda Medical Center |
|
P31-4Gynecology Pembrolizumab+lenvatinib combination chemotherapy for uterine carcinosarcoma
[Speaker] Hiroyuki Narahara:1,3 1:Hyogo Prefectural Nishinomiya Hospital, 3:Hyogo Prefectural Nishinomiya Hospital |
|
P31-5Gynecology Five cases of recurrent granulosa cell carcinoma who survived more than 10 years after recurrence with multiple surgeries and drug therapies
[Speaker] Kohei Tsunematsu:1 1:Obstetrics/Gynecology, Tama Nagayama Hospital, Nippon Medical School |
|
P31-6Gynecology A Study of Adverse Events of Niraparib Maintenance Therapy after Initial Chemotherapy in Advanced Ovarian Cancer
[Speaker] Kota Okamoto:1 1:Obstetrics&Gynecology, Hospital, Mie University |
|
P31-7Gynecology Two cases of ovarian granulosa cell tumor recurrence successfully treated with radiotherapy
[Speaker] Yoko Taima:1 1:Ishikawa Prefectural Central Hospital |
ePoster 32
Radiation therapy
October 20 (Fri) 9:20 - 9:55 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P32-1Radiation therapy Treatment outcomes of stereotactic irradiation for brain metastases from digestive-organ cancer
[Speaker] Yasushi Hamamoto:1 1:Department of Radiology, National Hospital Organization Shikoku Cancer Center |
|
P32-2Radiation therapy Radical radiotherapy for elderly lung cancer patients aged 80 and over
[Speaker] Tsuyoshi Takanaka:1 1:Department of Radiation Oncology, Koseiren Takaoka Hospital |
|
P32-3Radiation therapy Visualization of Ra-223 using whole-body planar imaging
[Speaker] Soichi Makino:1 1:Shin-kuki General Hospital |
|
P32-4Radiation therapy Survival Prediction for Patients with Vertebral Bone Metastases Treated with Radiotherapy
[Speaker] Kazuya Takeda:1,2 1:Department of Radiation Oncology, Graduate School of Medicine, Tohoku University, 2:Department of Radiation Oncology, South Miyagi Medical Center |
|
P32-5Radiation therapy Scoring system for the patients with bone metastatic lung cancer treated with palliative radiotherapy
[Speaker] Kenji Makita:1,2,4 1:National Hospital Organization Shikoku Cancer Center, 2:Department of Radiology, Graduate School of Medicine, Ehime University, 4:Ehime Prefectural Central Hospital |
ePoster 33
Palliative therapy 1
October 20 (Fri) 10:30 - 11:15 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P33-1Palliative therapy Development of an educational program to improve the knowledge and support skills of health care providers regarding cognitive dysfunction associated with breast cancer treatment
[Speaker] Azumi Onitsuka:1 1:Department of Human Health Science, Graduate School of Medicine, Kyoto University |
|
P33-2Palliative therapy Effects of elobixibat hydrate on constipation in patients taking opioids
[Speaker] Toshiki Etani:1 1:Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University |
|
P33-3Palliative therapy A study for the feasibility of food containing Acanthopanax senticosus for treating patients with cancer related fatigue
[Speaker] Yutaka Kawano:1,3 1:Department of gastroenterology and oncology, Graduate School, The University of Tokushima, 3:Department of community medicine and medical science, Graduate School, The University of Tokushima |
|
P33-4Palliative therapy Comparative study of symptomatic relief of cancer-related arterial thrombosis and cancer-related venous thrombosis
[Speaker] Masako Akashi:1 1:Japanese Red Cross Musashino Hospital |
|
P33-5Palliative therapy Virtual reality-guided rehabilitation trial for chemotherapy-induced peripheral neuropathy
[Speaker] Chieko Miyata:1,2 1:Palliative Care, National Hospital Organization Tokyo Medical Center, 2:Cancer rehabilitation, National Hospital Organization Tokyo Medical Center |
|
P33-6Palliative therapy A Case of Prolonged Hypomagnesaemia Caused by Concomitant Use of Methadone for Intractable Cancer Pain During Carboplatin-Containing Chemotherapy
[Speaker] Masako Akashi:1 1:Japanese Red Cross Musashino Hospital |
ePoster 34
Palliative therapy 2
October 20 (Fri) 11:20 - 12:05 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P34-1Palliative therapy Cases of perospirone used to prevent nausea and delirium, a side effect of opioids
[Speaker] Kazuho Yoshino:1,2 1:Department of Palliative Care, Odawara Municipal Hospital, 2:Cancer Support Team, Odawara Municipal Hospital |
|
P34-2Palliative therapy Opioid initiation as a predictor of prognosis in patients with terminal cancer
[Speaker] Naoko Yamamoto:1 1:Department of Pharmacy, Hino Hospital |
|
P34-3Palliative therapy Change in the number of palliative care interventions after the introduction of distress screening for all inpatients
[Speaker] Asumi Taneichi:1 1:Nursing Department, Odawara Municipal Hospital |
|
P34-4Palliative therapy A fact-finding survey of domestic palliative care and rehabilitation for far advanced diseases at a clinic for home medical care
[Speaker] Kazunari Abe:1 1:Department of rehablilitation, Honaminosato clinic |
|
P34-5Palliative therapy Effects of COVID-19 on hospitalized patients treated by the cancer support team―Odawara Municipal Hospital Cases―
[Speaker] Kazuho Yoshino:1,2 1:Department of Palliative Care, Odawara Municipal Hospital, 2:Cancer Support Team, Odawara Municipal Hospital |
|
P34-6Palliative therapy Initiatives at the Breast Center for the patient with Malignant Tumors of Unknown primary origin
[Speaker] Noriyoshi Tanaka:1 1:Breast Center, National Hospital Organization Saitama National Hospital |
ePoster 35
Bone and soft tissue
October 20 (Fri) 13:35 - 14:10 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P35-1Bone and soft tissue A case of chondroblastic osteosarcoma of pelvis with a preoperative pathological diagnosis of chondrosarcoma (grade 1-2)
[Speaker] Yuta Taniguchi:1 1:Department of Orthopaedic Surgery, Hospital, Kanazawa University |
|
P35-2Bone and soft tissue A case of total pelvic exenteration with posterior approach for a large pelvic tumor
[Speaker] Hideaki Tsumuraya:1 1:Department of Gastrointestinal Tract Surgery, Fukushima Medical University |
|
P35-3Bone and soft tissue A case of malignant peripheral nerve sheath tumor in the obturator nerve without neurofibromatosis
[Speaker] Seito Fujibayashi:1 1:Gastroenterological Surgery, Hospital, Gifu University |
|
P35-4Bone and soft tissue Serial Magnetic Resonance Imaging Changes in Sarcoma Presenting Compartment Syndromes: a case report
[Speaker] Hirokazu Shimizu:1,2 1:Department of Orthopedic Surgery, School of Medicine, Hokkaido University, 2:Department of Musculoskeletal Oncology, National Hospital Organization -Hokkaido Cancer Center- |
| P35-5Bone and soft tissue Withdrawn |
ePoster 36
Orthopedics, Skin
October 20 (Fri) 14:25 - 15:00 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P36-1Orthopedics, Skin The analysis of bone union after internal fixation for impending or pathological fracture of metastatic femoral bone tumor
[Speaker] Tomoaki Mori:1 1:Department of Orthopaedic Surgery, School of Medicine, Keio University |
|
P36-2Orthopedics, Skin Soft tissue-preserving procedure of hip disarticulation for chronic infection of the distal femoral tumor prosthesis: a case report
[Speaker] Tsuyoshi Mizuma:1 1:Department of Orthopaedic Surgery, School of Medicine, Keio University |
|
P36-3Orthopedics, Skin Two cases of limited shoulder joint range-of-motion due to chemotherapy extravasation from an anterior chest CV port
[Speaker] Hirokazu Furuta:1 1:National Hospital Organization Tokyo Medical Center |
|
P36-4Orthopedics, Skin A single-center retrospective study of the prognosis of advanced stage extramammary Paget's disease
[Speaker] Takeru Funakoshi:1 1:Department of Dermatology, School of Medicine, Keio University |
|
P36-5Orthopedics, Skin A patient with stage IV colorectal cancer in complete remission lost to sepsis due to sacral squamous cell carcinoma
[Speaker] Masayoshi Nagahama:1 1:Department of Surgery, Naha City Hospital |
ePoster 37
Nursing 1
October 20 (Fri) 15:45 - 16:20 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P37-1Nursing Nurses' understanding of skin problems during anticancer drug treatment in a gastrointestinal surgery ward
[Speaker] Akemi Harada:1 1:JR Sapporo Hospital |
|
P37-2Nursing Investigation of the current situation and consideration of issues for efficient management in the outpatient chemotherapy room
[Speaker] Yuki Yabuki:1 1:National Kyushu Medical Center |
|
P37-3Nursing Standardization of pamphlet creation and guidance in multidisciplinary cancer chemotherapy
[Speaker] Tsubasa Funakoshi:1 1:STEEL MEMORIAL YAWATA HOSPITAL |
|
P37-4Nursing Report on work support activities for cancer survivors by Coordinators to support balancing work and medical treatment at Hospital of the University of Occupational and Environmental Health, Japan
[Speaker] Etsuko Hosoda:1 1:Support Center of Treatment and Work Balance, University Hospital, University of Occupational and Environmental Health |
|
P37-5Nursing Current states and issues of our hospital based on the results of questionnaires aimed at improving the quality of life for patients with cancer and their families
[Speaker] Nana Kusano:1 1:Clinical Oncology Center, Hospital, Nagasaki University |
ePoster 38
Nursing 2
October 20 (Fri) 16:35 - 17:10 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
| P38-1Nursing Withdrawn |
|
P38-2Nursing Assessment of Nurses' Role Activities and Practical Competencies Related to Palliative Care Challenges
[Speaker] Miwako Miura:1,2 1:Tokyo Saiseikai Central Hospital, 2:International University of Health and Welfare Graduate School |
|
P38-3Nursing Changes in posttraumatic growth among advanced / recurrent cancer survivors who undergo counseling and support services provided by Certified Nurse Specialist in cancer nursing
[Speaker] Masami Hanade:1 1:The Cancer Institute Hospital |
|
P38-4Nursing What is the ethics of cancer counseling?―Looking back on the “Northern Kanto Koshinetsu Consultation Support Forum in Tochigi”―
[Speaker] Emi Mizuno:1 1:Nasu Red Cross Hospital |
|
P38-5Nursing An Analysis of Support for Terminally Adolescent and young adult (AYA) Cancer Patients and Their Families: A Case Study Using the Double ABC-X Model
[Speaker] Michiyo Miyatake:1 1:Nursing department, Nagoya Ekisaikai Hospital |
ePoster 39
Colorectal (drug) 1
October 20 (Fri) 8:30 - 9:20 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P39-1Colorectal (drug) A case report of transverse colon cancer with NTRK fusion gene
[Speaker] Kensuke Saito:1 1:Oncology, Graduate of Medicine, Hirosaki University |
|
P39-2Colorectal (drug) Experience of Stage IV colorectal cancer that has been treated for 72 months with rechallenge/change of anti-EGFR/VEGF antibody drug
[Speaker] Kazuto Kojima:1 1:Oncology, Kasukabe Central General Hospital |
|
P39-3Colorectal (drug) Conversion of HER2 status from negative to positive after anti-EGFR antibody treatment: two case reports
[Speaker] Naoaki Kodama:1 1:Department of Clinical Oncology / Division of Cancer Chemotherapy, Graduate School of Medicine, Akita University |
|
P39-4Colorectal (drug) A case of heavily treated metastatic colon cancer with EGFR gene amplification and rearrangements, benefited from panitumumab monotherapy
[Speaker] Taro Sato:1 1:Department of Gastroenterology and Hepatology, Hospital, Kyorin University |
|
P39-5Colorectal (drug) Experience of pertuzumab + trastuzumab therapy for HER2-positive unresectable recurrent colorectal cancer
[Speaker] Shinji Furuya:1 1:First Department of Surgery, Faculty of Medicine, University of Yamanashi |
|
P39-6Colorectal (drug) OncoBEAM™ RAS CRC kit in advanced colorectal cancer: A single center experience
[Speaker] Kazuma Ito:1 1:Department of Surgery, Division of Lower Gastrointestinal Surgery, Hyogo Medical University |
|
P39-7Colorectal (drug) Current status of hospitalization chemotherapy of patients with Stage4 colorectal cancer in our hospital
[Speaker] Takahiro Kawabe:1 1:Rehabilitaion Department, Marimo Council Medical Corporation Hiroshima Hiramatsu Hospital |
ePoster 40
Colorectal (drug) 2
October 20 (Fri) 9:20 - 10:10 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P40-1Colorectal (drug) Risk factor of recurrence in patients who completed adjuvant chemotherapy in stage III colorectal cancer
[Speaker] Kosuke Sugiyama:1 1:Second department of surgery, University Hospital, Hamamatsu University School of Medicine |
|
P40-2Colorectal (drug) Postoperative adjuvant chemotherapy with oxaliplatin for Stage IIIb and IIIc colon cancer
[Speaker] Kazushige Furuya:1 1:Yamanashi Prefectural Central Hospital |
|
P40-3Colorectal (drug) Safety of the postoperative adjuvant chemotherapy for colorectal cancer in patients aged 75 years or older
[Speaker] Akinobu Yasuyama:1 1:Department of Surgery, Osaka Rosai Hospital |
| P40-4Colorectal (drug) Withdrawn |
| P40-5Colorectal (drug) Withdrawn |
|
P40-6Colorectal (drug) Efficacy and adverse events of Trifluridine/Tipiracil (FTD/TPI) therapy for unresectable advanced colorectal cancer in the elderly, a single center retrospective study
[Speaker] Takashi Jin:1 1:Tonan-Hospital |
|
P40-7Colorectal (drug) An 80-year-old case of liver metastasis from unresectable colorectal cancer undergoing chemotherapy with an emphasis on QOL and living for a long time
[Speaker] Masayoshi Kobayashi:1 1:Kobe Century Memorial Hospital |
ePoster 41
Colorectal (drug) 3
October 20 (Fri) 10:30 - 11:15 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P41-1Colorectal (drug) Binimetinib, encorafenib and cetuximab (BEACON study) for patients with BRAF V600E mutation-positive metastatic colorectal cancer
[Speaker] Sakiko Nakamori:1 1:Department of Colorectal surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital |
|
P41-2Colorectal (drug) A case of BRAF V600E mutant metastatic colon cancer with dementia treated by encorafenib plus cetuximab
[Speaker] Shoichi Kinugasa:1 1:Surgery, Public Shiso General Hospital |
|
P41-3Colorectal (drug) A case of pembrolizumab-refractory locally recurrent colorectal cancer with significant response to encorafenib and cetuximab
[Speaker] Kaori Fukuda:1 1:Department of Surgery, Sendai City Hospital |
|
P41-4Colorectal (drug) 4 case reports of BRAF-mutat unresectable metastatic colorectal cancer at our hospital
[Speaker] Hitoshi Soda:1 1:Department of Surgery, Japan Community Health care Organization Yamanashi Hospital |
|
P41-5Colorectal (drug) A case of parotid metastasis from rectal cancer that resulted in a rapid clinical course
[Speaker] Kanako Suenaga:1 1:Department of G-I Tract Surgery, Fukushima Medical University |
|
P41-6Colorectal (drug) A case of sigmoid colon cancer with multiple and massive liver metastases presenting spontaneous tumor lysis syndrome
[Speaker] Masanori Takehara:1 1:Department of Gastroenterology, Tokushima Red Cross Hospital |
ePoster 42
Colorectal (drug) 4
October 20 (Fri) 11:20 - 12:10 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P42-1Colorectal (drug) A case of recurrent transverse colon cancer patient successfully treated with pembrolizumab and hepatectomy despite of severe skin adverse event
[Speaker] Ikuo Takahashi:1 1:Department of Surgery, Tagawa Municipal Hospital |
|
P42-2Colorectal (drug) A case of tumor perforation during pembrolizumab to MSI-High colon cancer
[Speaker] Michiaki Shimada:1 1:1st Department, Faculty of Medical Sciences, University of Fukui |
|
P42-3Colorectal (drug) Treatment of unresectable MSI-H colon cancer with pembrolizumab
[Speaker] Koya Yokoyama:1 1:Department of Surgery, Japanese Red Cross Narita Hospital |
|
P42-4Colorectal (drug) Three cases using immune checkpoint inhibitors for advanced and recureent MSI-H colorectal cancer
[Speaker] Kenji Matsuda:1 1:Second Department of Surgery, Wakayama Medical University |
|
P42-5Colorectal (drug) A case of MSI-High colon cancer suffered from 4 gastrointestinal irAEs by ipilimumab/nivolumab therapy
[Speaker] Takafumi Sasada:1 1:Department of Gastroenterology and Hematology, Graduate of Medicine, Hirosaki University |
|
P42-6Colorectal (drug) Significance of irAE as a predictor of response to immune checkpoint inhibitors for rectal malignant melanoma
[Speaker] Reiko Yokoyama:1 1:Gastroenterology, Hospital, Tokushima University |
|
P42-7Colorectal (drug) Clinical feature and course of a severe type of erythema multiforme (EM major) during administration of anti-PD-1 antibody, pembrolizumab
[Speaker] Ryohei Kadoi:1 1:Depertment of Clinical Oncology, Graduate School of Medicine, Akita University |
ePoster 43
Pharmacology 1
October 20 (Fri) 13:35 - 14:20 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P43-1Pharmacology A Descriptive Analysis of Real-world Trastuzumab BS-Pfizer Use for Breast and Gastric Cancer in Japan
[Speaker] Chiho Ono:1 1:Medical Affairs, Pfizer Japan Inc. |
|
P43-2Pharmacology A retrospective survey and literature review of abemaciclib therapy: A single-institution experience
[Speaker] Yu Takahashi:1 1:Department of Clinical Pharmacology and Therapeutics, Hospital, Kyoto University |
|
P43-3Pharmacology Survey of olanzapine use in pre- and postoperative AC/EC adjuvant chemotherapy in breast cancer patients
[Speaker] Maho Yamada:1 1:Department of pharmacy, Hospital, Mie University |
|
P43-4Pharmacology A case of effective use of duloxetine for pain caused by taxane acute pain syndrome
[Speaker] Yuko Miyake:1 1:Pharmacy, Hospital, Teikyo University |
|
P43-5Pharmacology Re-administration of Pertuzumab and trastuzumab after an Infusion related reaction : A case report
[Speaker] Honami Katahara:1 1:National Cancer Center Hospital East |
|
P43-6Pharmacology Analysis of pharmaceutical intervention by Counseling before Examination by the Pharmacist for Breast Cancer Outpatients Chemotherapy Patients
[Speaker] Shohei Kaneko:1 1:Kaizuka City Hospital |
ePoster 44
Pharmacology 2
October 20 (Fri) 14:25 - 15:10 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P44-1Pharmacology Risk factors for emergency hospitalization of DCF therapy for locally advanced esophageal cancer
[Speaker] Kensuke Mayumi:1 1:Department of Pharmacy, National Cancer Center Hospital East |
|
P44-2Pharmacology Safety of ambulatory treatment in 5-fluorouracil and cisplatin combined with immune checkpoint inhibitor for unresectable advanced, recurrent, or metastatic esophageal cancer
[Speaker] Daigaku Nakamura:1 1:Department of Pharmacy, Hospital, Nagoya City University |
|
P44-3Pharmacology A Descriptive Analysis of Real-World Bevacizumab BS-Pfizer Use in Colorectal and Non-small Cell Lung Cancer in Japan
[Speaker] Chiho Ono:1 1:Medical Affairs, Pfizer Japan Inc. |
|
P44-4Pharmacology Evaluation of usefulness of urine quantitative test in FOLFIRI + Ramucirumab therapy for metastatic colorectal cancer
[Speaker] Naomi Hanatani:1 1:Pharmaceutical department, Medical center, Yokohama City University |
|
P44-5Pharmacology Examination of the incidence of myelosuppression and reasons for discontinuation in patients treated with trifluridine and tipiracil
[Speaker] Tsuyoshi Yamada:1 1:Department of Pharmacy, Oita Prefectural Hospital |
|
P44-6Pharmacology Examination of side effects due to difference in the timing of lenvatinib introduction in patients with hepatocellular carcinoma
[Speaker] Yukio Sakata:1 1:Department of Pharmacy, Hakodate Municipal Hospital |
ePoster 45
Pharmacology 3
October 20 (Fri) 15:45 - 16:20 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P45-1Pharmacology A case study of the usefulness of online follow-up for a patient with non-small cell lung cancer residing in a remote area
[Speaker] Yuki Oka:1 1:NIHON CHOUZAI Co., Ltd. |
|
P45-2Pharmacology A case of readministration after drug-induced interstitial pneumonitis caused by Olaparib treatment
[Speaker] Yumiko Saeki:1 1:Department of Pharmacy, Matsue City Hospital |
|
P45-3Pharmacology Investigation on the Optimal AUC Values for Carboplatin Dosage Determination in R-DeVIC Therapy
[Speaker] Keishi Fukuura:1 1:Department of Medicine, Suzuka Kaisei Hospital |
|
P45-4Pharmacology Comparison of efficacy and incidence of adverse effects of subcutaneous Daratumumab by body weight
[Speaker] Yusuke Nakamura:1 1:Department of Pharmacy, Sapporo Hokuyu Hospital |
|
P45-5Pharmacology Analysis of irAE profile in cancer patients treated with long-term and short-term nivolumab
[Speaker] Nanami Ito:1,2 1:Pharmacy, Hospital, Nagoya City University, 2:Clinical pharmaceutics, Graduate School of Medical Sciences, Nagoya City University |
ePoster 46
Pancreas・Billary tract (drug)
October 20 (Fri) 16:35 - 17:25 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P46-1Pancreas・Billary tract (drug) Retrospective study of mFFX and nal-IRI + 5-FU/LV as the second-line chemotherapy for advanced pancreatic cancer
[Speaker] Shiori Ishikawa:1 1:Medical Oncology, Osaki Citizen Hospital |
|
P46-2Pancreas・Billary tract (drug) A Study of 10 Patients Treated with Nanoliposomal Irinotecan (nal-IRI) +5FU/LV Therapy for Unresectable Pancreatic Cancer
[Speaker] Kouji Kobayashi:1 1:Medical Oncology, Koto Toyosu Hospital, Showa University |
|
P46-3Pancreas・Billary tract (drug) Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study
[Speaker] Satoshi Kobayashi:1 1:Kanagawa Cancer Center |
|
P46-4Pancreas・Billary tract (drug) Association between Homologous Recombination Repair Gene Mutations and Efficacy of Oxaliplatin in Invasive Pancreatic Ductal Adenocarcinoma Using Gene Panel Testing at Our Hospital
[Speaker] Ryosuke Maki:1 1:Gastroenterology, Graduate School of Medicine, Osaka University |
|
P46-5Pancreas・Billary tract (drug) A case of EGFR-amplified advanced biliary tract cancer successfully treated with Necitumumab
[Speaker] Makoto Sugimori:1,2 1:Division of Cancer Genome Medicine, Medical center, Yokohama City University, 2:Department of Gastroenterology, Gastroenterological center, Medical center, Yokohama City University |
|
P46-6Pancreas・Billary tract (drug) Retrospective Analysis of the Impact of Systemic Chemotherapy Treatment on HER3 Expression in Biliary Tract Cancers
[Speaker] Mariko Nishioka:1 1:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital |
|
P46-7Pancreas・Billary tract (drug) Interim analysis for post-marketing surveillance of pemigatinib therapy in Japanese patients with biliary tract cancer harboring a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement
[Speaker] Koki Kabu:1 1:Medical Affairs, Incyte Biosciences Japan G.K. |
ePoster 47
Genomic medicine, Medical data
October 20 (Fri) 10:30 - 11:05 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
|
P47-1Genomic medicine, Medical data The challenge of re-search of clinical trials after expert panel for CGP tests
[Speaker] Yuko Yamaguchi:1 1:Osaka International Cancer Institute |
|
P47-2Genomic medicine, Medical data Examination of the issues before and after the cancer genomic profiling test
[Speaker] Motonobu Saito:1 1:Department of Gastrointestinal Tract Surgery, School of Medicine, Fukushima Medical University |
|
P47-3Genomic medicine, Medical data Comprehensive cancer genomic profiling test improves prognosis in neuroendocrine carcinomas of the gastrointestinal system
[Speaker] Shinichi Nishina:1,2 1:Medical Oncology, Kurashiki Central Hospital, 2:Surgery, Kurashiki Central Hospital |
|
P47-4Genomic medicine, Medical data Correlation between tumor grade distribution and gene alteration in urological cancers
[Speaker] Kosuke Mizutani:1,4 1:Department of Urology, Central Japan International Medical Center, 4:Cancer Genomic Testing & Treatment Center, Central Japan International Medical Center |
|
P47-5Genomic medicine, Medical data Multicenter collaborative study on real-world data (RWD) collection in cancer care with CyberOncology® platform (CONNECT trial).
[Speaker] Shigemi Matsumoto:1 1:Department of Real World Data R & D, Graduate School of Medicine, Kyoto University |
ePoster 48
Oncofertility
October 20 (Fri) 11:20 - 11:50 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
|
P48-1Oncofertility Male infertility in testicular cancer survivors at our institution
[Speaker] Hatsuki Hibi:1,3 1:Department of Urology, Minato Medical Coop-Kyoritsu General Hospital, 3:Department of Gynecology & Obstetrics, Asada Ladies Clinic |
|
P48-2Oncofertility Approach to Fertility Preservation for Hereditary Breast and Ovarian Cancer Syndrome (HBOC)
[Speaker] Yumiko Taura:1,2 1:Department of Clinical Genetics and Medicine, Hospital, Kyushu University, 2:Department of Obstetrics and Gynecology, Hospital, Kyushu University |
|
P48-3Oncofertility The Situation of the Consultation about Pregnant Cancer Patients in Cancer Hospitals: Study for Certified Nursing Specialists and Certified Nurses
[Speaker] Rie Hori:1 1:Department of Nursing, KANSAI University of Social Welfare |
|
P48-4Oncofertility Details
[Speaker] Ikuko Chiba:1 1:National Cancer Center Hospital East |
ePoster 49
Hematology, Rare cancer
October 20 (Fri) 15:45 - 16:35 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
|
P49-1Hematology, Rare cancer The efficacy and safety of Pola-R-CHP and Pola-BR therapies in our hospital
[Speaker] Kazuhiro Suzuki:1 1:Medical oncology, Misawa City Hospital |
| P49-2Hematology, Rare cancer Withdrawn |
|
P49-3Hematology, Rare cancer Disease flare after discontinuation of everolimus in patients with pancreatic neuroendocrine tumor
[Speaker] Satoshi Shimizu:1 1:Department of Gastroenterology, Saitama Prefecture Cancer Center |
|
P49-4Hematology, Rare cancer A case of cancer of unknown primary that responded to Nivolumab therapy
[Speaker] Wakana Chikaishi:1 1:Department of Gastroenterological Surgery and Pediatric Surgery, Graduate School of Medicine, Gifu University |
|
P49-5Hematology, Rare cancer Response to Capmatinib in a Patient with Neuroendocrine Carcinoma of the Gallbladder Origin harboring MET Amplification
[Speaker] Shogo Yamamura:1 1:Department of Clinical Oncology, Hospital, Kyoto University |
|
P49-6Hematology, Rare cancer A case of Solitary Fibrous Tumor responding to Pazopanib
[Speaker] Yoshinori Kikuchi:1 1:Department of Clinical Oncology, Faculty of Medicine, Toho University |
|
P49-7Hematology, Rare cancer Prognosis of Penile Squamous Cell Carcinoma and Extramammary Paget Disease in Japan: An Analysis of Nationwide Hospital-based Cancer Registry Data
[Speaker] Shuya Kandori:1 1:Department of Urology, Institute of Medicine, Tsukuba University |
ePoster 50
Breast (diagnosis, prognosis)
October 20 (Fri) 16:35 - 17:10 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
|
P50-1Breast (diagnosis, prognosis) Investigation of The Cancer Genome Panel for Breast Cancer in our hospital
[Speaker] Yoshimi Asano:1 1:Breast surgery, School of Medicine, Gifu University |
|
P50-2Breast (diagnosis, prognosis) BRCA genetic testing system and treatment for breast cancer patients at our hospital
[Speaker] Kaeko Oyama:1 1:Koseiren Takaoka Hospital |
|
P50-3Breast (diagnosis, prognosis) Significance of Skeletal Muscle Measurement by Preoperative CT in Elderly Patients with Resected Breast Cancer
[Speaker] Takahiro Akahori:1 1:Department of Surgery, Hospital, Nara Medical University |
|
P50-4Breast (diagnosis, prognosis) Investigation of the clinical and pathological features of TNBC in elderly patients and their treatment outcomes in our institution
[Speaker] Arisa Kurita:1 1:Department of Surgery, School of Medicine, Keio University |
|
P50-5Breast (diagnosis, prognosis) Exploratory study to provide the best medical care for locally advanced breast cancer patients with ulcers
[Speaker] Kanako Sugiyama:1 1:Breast care, Saitama Medical Center, Saitama Medical University |


